Currently, 80% of in-country pharmaceutical drug demand is met through imports, highlighting significant growth potential for the UAE pharmaceutical sector. The emphasis is on attracting international pharmaceutical companies into the country and developing local pharmaceutical product manufacturers. The combination of the two will achieve self-sufficiency, meet the needs of a growing population and, importantly, build knowledge and expertise locally. In addition, the UAE is investing in emerging vaccine methods and innovative drugs and is poised to become a key pharmaceutical research and development hub.
Although the UAE already ranks among the fastest nations for drug approvals, it plans to further shorten the timeline for the approval of medical products.
Sector Key Numbers
USD 355 per capital
Expenditure on pharmaceuticals in 2020, from USD 344 in 2019
1% of MVA
Pharma constitutes only 1% of the Manufacturing Value Add (2018)
The sector’s contribution to the GDP is projected to increase by 150% over the next 10 years
UAE’s projected spend on generic drugs by 2030, translating to a CAGR of 7.3%
Explore The Sector
Targeted enablement to localize an integrated generic drug manufacturing value chain
The UAE is investing in emerging vaccine production methods
80% of local pharmaceutical drug demand has to be imported, which allows for significant growth in this sector through the localization of pharmaceutical drug manufacturing